Article info

Download PDFPDF
Original research
CDK1/2/5 inhibition overcomes IFNG-mediated adaptive immune resistance in pancreatic cancer

Authors

  1. Correspondence to Dr Daolin Tang, Department of Surgery, UT Southwestern Medical Center, Dallas, Texas, USA; daolin.tang{at}utsouthwestern.edu; Dr Rui Kang, Department of Surgery, UT Southwestern Medical Center, Dallas, Texas, USA; rui.kang{at}utsouthwestern.edu
View Full Text

Citation

Huang J, Chen P, Liu K, et al
CDK1/2/5 inhibition overcomes IFNG-mediated adaptive immune resistance in pancreatic cancer

Publication history

  • Received December 9, 2019
  • Revised July 3, 2020
  • Accepted July 14, 2020
  • First published August 14, 2020.
Online issue publication 
April 07, 2021

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.